Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 8
1948 4
1949 1
1950 2
1951 1
1952 1
1953 1
1955 6
1956 4
1957 2
1958 2
1959 1
1960 3
1961 2
1962 3
1963 2
1964 3
1965 5
1966 2
1967 4
1968 3
1970 8
1971 3
1972 4
1973 4
1974 8
1975 1
1976 4
1977 4
1978 2
1979 8
1980 11
1981 3
1982 14
1983 15
1984 12
1985 22
1986 23
1987 33
1988 48
1989 44
1990 57
1991 53
1992 84
1993 76
1994 106
1995 116
1996 117
1997 162
1998 157
1999 193
2000 232
2001 253
2002 280
2003 395
2004 470
2005 620
2006 718
2007 791
2008 989
2009 1197
2010 1437
2011 1734
2012 2054
2013 2557
2014 2955
2015 3306
2016 3558
2017 3846
2018 4568
2019 5486
2020 6935
2021 7915
2022 9692
2023 9547
2024 4394
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

68,856 results

Results by year

Filters applied: . Clear all
Page 1
Author Correction: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress.
Liu X, Viswanadhapalli S, Kumar S, Lee TK, Moore A, Ma S, Chen L, Hsieh M, Li M, Sareddy GR, Parra K, Blatt EB, Reese TC, Zhao Y, Chang A, Yan H, Xu Z, Pratap UP, Liu Z, Roggero CM, Tan Z, Weintraub ST, Peng Y, Tekmal RR, Arteaga CL, Lippincott-Schwartz J, Vadlamudi RK, Ahn JM, Raj GV. Liu X, et al. Among authors: li m. Nat Cancer. 2024 May 20. doi: 10.1038/s43018-024-00783-4. Online ahead of print. Nat Cancer. 2024. PMID: 38769429 No abstract available.
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.
Cevik M, Thompson LC, Upton C, Rolla VC, Malahleha M, Mmbaga B, Ngubane N, Abu Bakar Z, Rassool M, Variava E, Dawson R, Staples S, Lalloo U, Louw C, Conradie F, Eristavi M, Samoilova A, Skornyakov SN, Ntinginya NE, Haraka F, Praygod G, Mayanja-Kizza H, Caoili J, Balanag V, Dalcolmo MP, McHugh T, Hunt R, Solanki P, Bateson A, Crook AM, Fabiane S, Timm J, Sun E, Spigelman M, Sloan DJ, Gillespie SH; SimpliciTB Consortium. Cevik M, et al. Lancet Infect Dis. 2024 May 17:S1473-3099(24)00223-8. doi: 10.1016/S1473-3099(24)00223-8. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38768617
Discovery and engineering of Tsp2Cas9 for genome editing.
Mao H, Tian Y, Wang Z, Liu J, Wei J, Wang Y, Tao C, Li M, Wang S, Shen L, Tang J, Wang R, Gao S, Lan F, Wang Y. Mao H, et al. Among authors: li m. Cell Discov. 2024 May 21;10(1):55. doi: 10.1038/s41421-024-00685-w. Cell Discov. 2024. PMID: 38769322 No abstract available.
68,856 results
You have reached the last available page of results. Please see the User Guide for more information.